Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 274,55 € (+0,38 %). Medianen er 280,59 € (+2,59 %).
| Køb |
29 |
| Behold |
13 |
| Sælg |
1 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Veeva Systems raises annual targets after strong quarter thanks to Vault CRM and AI agents
Veeva Systems beat expectations in the second quarter: revenue rose 18% to $928 million, subscriptions increased 16%, and adjusted earnings per share were $2.35. Management raised the full-year forecast and now expects up to $3.687 billion in revenue and earnings per share of around $9.21. The Vault CRM solution and AI agents were cited as stock drivers, while Veeva continues to expand its market-leading position in the life‑sciences sector. » Mere på finanzen.net
Veeva deepens AI strategy at Citi Global TMT Conference 2026
Veeva emphasized at the conference that about 98% of revenue still comes from the life sciences sector, commercial subscriptions recently showed roughly 13% year‑over‑year growth, and R&D growth has slowed to mid single‑digit to mid‑teens percentages. The newly positioned Falcon platform is intended to automate agent‑based end‑to‑end workflows, complemented by Vault AI for user‑centric productivity features; pricing for AI products will be transaction‑ and usage‑based to preserve software‑like margins. Veeva signals cautious but accelerated AI deployment, opportunistic acquisitions to speed the roadmap, and is launching Aspen as a standalone CRM initiative outside the core sector. » Mere på de.investing.com
Veeva Systems establishes itself as operating system of the pharmaceutical industry with a massive moat
Veeva Systems offers cloud software exclusively for the life‑sciences sector and is used by more than 1,500 pharmaceutical, biotech, and medical‑technology companies for clinical trials, regulatory approval, quality, drug safety, and marketing. Products such as Vault CRM, Development Cloud, Quality Cloud, and Data Cloud are deeply embedded in regulated workflows, creating high switching costs and a strong moat. Veeva is targeting a market share of over 70% and sees AI features as extending this competitive advantage. » Mere på finanzen.net
Veeva exceeds expectations thanks to AI push
Veeva reports better-than-expected revenue and earnings, driven by an AI strategy that CEO Peter Gassner called "the next big chapter." Its core product Vault CRM posted its strongest quarter and is in use at more than 180 customers, including twelve of the 20 largest biopharma companies. The development of agentic AI is also creating new product and growth opportunities. » Mere på finanzen.net
Veeva Systems beats Q2 expectations and raises full-year outlook
Veeva Systems reported adjusted EPS of $2.35 for the quarter ended July 31 (expectation $2.22) and revenue of $928m (expectation $905.4m). Revenue from commercial subscriptions rose 13%, the company recorded its best CRM quarter and has more than 180 Vault-CRM customers live. Management raised the fiscal 2027 outlook, cited Falcon and other new products as growth drivers, and emphasized the shift to next‑gen R&D offerings. The stock rose about 9.4% in after‑hours trading to $268. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juli 2026 | YoY |
|---|---|---|
| Omsætning | 804,36 mio. | 16,44 % |
| Bruttofortjeneste | 603,25 mio. | 16,05 % |
| Nettoresultat | 237,01 mio. | 35,16 % |
| EBITDA | 312,4 mio. | 29,54 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 44,78 mia. € |
Antal aktier | 161,91 mio. |
Højeste/laveste i 52 uger | 295,06 € - 134,00 € |
| Udbytte | Nej |
Beta | 0,90 |
P/E (PE Ratio) | 49,20 |
PEG (PEG Ratio) | 1,99 |
K/I (PB Ratio) | 6,67 |
P/S (PS Ratio) | 14,31 |
Virksomhedsprofil
Veeva Systems Inc. leverer cloudbaseret software til life sciences-branchen i Nordamerika, Europa, Asien-Stillehavsområdet, Mellemøsten, Afrika og Latinamerika. Virksomheden tilbyder Veeva Commercial Cloud, en pakke af software-, data- og analyseløsninger, som omfatter Veeva customer relationship management (CRM) og Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud og MyVeeva for Patients; samt Veeva Vault, en cloudbaseret applikation til virksomhedens indholds- og datahåndtering til styring af kommercielle funktioner, herunder salg og markedsføring samt medicinsk indhold og kommunikation, samt forsknings- og udviklingsfunktioner, såsom klinisk, regulatorisk, kvalitets- og sikkerhedsmæssig håndtering. Virksomheden leverer også professionelle services og supportydelser inden for implementering og udrulningsplanlægning samt projektledelse; kravanalyse, løsningsdesign og konfiguration; styring af systemmiljøer og udrulningsydelser; ydelser, der fokuserer på at udvikle eller transformere forretnings- og driftsprocesser relateret til Veeva-løsninger; tekniske konsulentydelser vedrørende datamigrering og systemintegrationer; uddannelse i sine løsninger; og løbende managed services, som omfatter outsourcet systemadministration. Virksomheden var tidligere kendt som Verticals onDemand, Inc. og ændrede navn til Veeva Systems Inc. i april 2009. Veeva Systems Inc. blev stiftet i 2007 og har hovedkontor i Pleasanton, Californien.
| Navn | Veeva Systems |
| CEO | Peter Gassner |
| Hjemsted | Pleasanton,
ca USA |
| Websted | |
| Sektor | Sundhed |
| Branche | Sundhedsteknologi |
| Børsnotering | 06.08.2014 |
| Medarbejdere | 7.928 |
Tickersymboler
| Børs | Symbol |
|---|---|
NYSE | VEEV |
London Stock Exchange | 0LO3.L |
XETRA | VEE.DE |
Frankfurt | VEE.F |
Düsseldorf | VEE.DU |
London | 0LO3.L |
SIX | VEE.SW |
München | VEE.MU |
Wien | VEEV.VI |
Milan | 1VEEV.MI |